Skip to content

Post-marketing safety study of Zuqamu Granules based on retrospective real-world data

Post-marketing safety study of Zuqamu Granules based on retrospective real-world data

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114638
Enrollment
Unknown
Registered
2025-12-16
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physiological dependence is manifested by withdrawal symptoms and signs after drug discontinuation, such as runny nose, tearing, sweating, dilated pupils, vomiting, diarrhea, muscle pain, restlessness, anxiety, and even loss of consciousness

Interventions

Observation group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.People who have taken Zuchamu Granules for = 15 days; 2.There was no prescription information for Zuchamu Granules in the 30 days prior to its use. 3.No history of drug abuse;

Exclusion criteria

Exclusion criteria: 1.Using other addictive drugs such as morphine, Demerol, Compound Licorice Tablets, etc. 2.Combined use of other traditional Chinese medicines containing opium shell ingredients such as Xuanlu Zixiu Keli, Qingshen Pipa Lu, Zhixuebao Pian, Zhonghong Huatan Pian, and Zhixiu Huatan Wan. 3.Combined use of sedative-hypnotic drugs such as barbiturates and benzodiazepines;

Design outcomes

Primary

MeasureTime frame
The incidence rate of ADRs caused by drug dependence;Factors influencing the incidence of adverse reactions;

Secondary

MeasureTime frame
The incidence rate of non-drug dependence-related adverse reactions;

Countries

China

Contacts

Public ContactHan Yong

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

hanyong@hust.edu.cn+86 15337295176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026